Sort
261,768 grants matching “gene therapy”
Primary Immune Deficiency Treatment Consortium
$1,249,464Morton Cowan · University Of California, San Francisco · U54 · FY2014 · AI
Autoimmune Drivers and Protectors Team Science (ADAPTS)
$1,249,430Judith A James · Oklahoma Medical Research Foundation · U01 · FY2025 · AI
Epithelial stem/progenitor cells as repair agents in diffuse alveolar damage
$1,249,427Harold A Chapman · University Of California, San Francisco · U01 · FY2018 · HL
Comparative Analysis of Cancer-Associated Genes and Development of a Gene Delive
$1,249,380Vladimir Larionov · Basic Sciences · Z01 · FY2007 · CA
Pathogenesis of Rett Syndrome
$1,249,276Hugo W. Moser Res Inst Kennedy Krieger · P01 · FY2003 · HD
Rare disease CRC for new therapies and new diagnostics
$1,249,253Baylor College Of Medicine · U54 · FY2005 · RR
Inherited Ocular Diseases
$1,249,198James F. Hejtmancik · National Eye Institute · ZIA · FY2012 · EY
Transcription and Therapy for HD: from Molecules to Man
$1,249,142Massachusetts General Hospital · P01 · FY2005 · NS
TAMAXIFEN PHARMACOGENETICS
$1,249,122Georgetown University · U01 · FY2000 · GM
Cannabinoid CB1 and CB2 receptors and drug abuse
$1,248,919Zheng-Xiong Xi · National Institute On Drug Abuse · ZIG · FY2021 · DA
P1 - Molecular Mechanisms of KIT Signaling and Imatinib Resistance in GIST
$1,248,914Cristina R Antonescu · Sloan-Kettering Inst Can Research · P50 · FY2010 · CA
Personalized Cystic Fibrosis Therapy and Research Center
$1,248,906Anjaparavanda P Naren · Cincinnati Childrens Hosp Med Ctr · P30 · FY2025 · DK
Defining and Manipulating Epigenomic Regulators in Endogenous Systems
$1,248,825Jordan Leslie Meier · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
RARE DISEASE CRC FOR NEW THERAPIES AND NEW DIAGNOSTICS
$1,248,799Baylor College Of Medicine · U54 · FY2004 · RR
Rare disease CRC for new therapies and new diagnostics
$1,248,799Baylor College Of Medicine · U54 · FY2004 · RR
Porphyria Rare Disease Clinical Research Consortium (RDCRC)
$1,248,797Robert J Desnick · Icahn School Of Medicine At Mount Sinai · U54 · FY2015 · DK
Restoration of free radical homeostasis: novel therapy of septic shock
$1,248,631Andrew L Salzman · Radikal Therapeutics, Inc. · R44 · FY2016 · GM
GENETIC APPROACHES FOR CANCER IMMUNOTHERAPY
$1,248,539University Of Michigan At Ann Arbor · P01 · FY2000 · CA
Rare disease CRC for new therapies and new diagnostics
$1,248,331Baylor College Of Medicine · U54 · FY2003 · RR
Tumor Intrinsic and Microenvironmental Mechanisms Driving Drug Combination Efficacy and Resistance in AML
$1,248,330Jeffrey Wallace Tyner · Oregon Health & Science University · U54 · FY2019 · CA
From therapeutic mechanisms to unraveling the pathophysiology of MS
$1,248,280Bibiana Bielekova · National Institute Of Neurological Disorders And Stroke · ZIA · FY2015 · NS
Transcription and Therapy for HD: from Molecules to Man
$1,248,267Massachusetts General Hospital · P01 · FY2004 · NS
Molecular and Cellular Therapies for Muscular Dystrophy
$1,248,156Stanley C Froehner · University Of Washington · P01 · FY2008 · NS
Predictive drivers of new onset, relapse, and progression of human autoimmunity in skin
$1,248,082John E Harris · Univ Of Massachusetts Med Sch Worcester · U01 · FY2024 · AI
Predictive drivers of new onset, relapse, and progression of human autoimmunity in skin
$1,248,082John E Harris · Univ Of Massachusetts Med Sch Worcester · U01 · FY2025 · AI